Inventor · disambiguated record
Thomas K. Karami
Also filed as: KARAMI THOMAS · KARAMI THOMAS K
6 granted patents·3 pending applications·6 citations·filing 2013–2021
73Inventor score
Top patents by PatentIndex Score
9 records- 0177US9120738B2Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereofALLERGAN INC·Filed 2013·Granted Sep 1, 2015·4 cites·17 claims
- 0272US9206228B2Crystalline form of cyclosporine A, methods of preparation, and methods for use thereofALLERGAN INC·Filed 2014·Granted Dec 8, 2015·1 cites·5 claims
- 0370US2021269484A1Crystalline form of cyclosporin a, methods of preparation, and methods for use thereofALLERGAN INC·Filed 2021·Application pending·0 cites
- 0467US9855232B2Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereofALLERGAN INC·Filed 2015·Granted Jan 2, 2018·1 cites·6 claims
- 0556US9447014B2Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereofALLERGAN INC·Filed 2013·Granted Sep 20, 2016·0 cites·20 claims
- 0654US9181176B27-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereofALLERGAN INC·Filed 2013·Granted Nov 10, 2015·0 cites·1 claims
- 0752US10273206B2Tromethamine salt of bimatoprost acid in crystalline form 1, methods for preparation, and methods for use thereofALLERGAN INC·Filed 2014·Granted Apr 30, 2019·0 cites·2 claims
- 0852US2016083432A1Crystalline form of cyclosporin a, methods of preparation, and methods for use thereofALLERGAN INC·Filed 2015·Application pending·0 cites
- 0951US2023118152A1Forms of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas K. Karami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →